Cargando…
In vitro and in vivo studies on gelatin-siloxane nanoparticles conjugated with SynB peptide to increase drug delivery to the brain
BACKGROUND: Nanobiotechnology can provide more efficient tools for diagnosis, targeted and personalized therapy, and increase the chances of brain tumor treatment being successful. Use of nanoparticles is a promising strategy for overcoming the blood–brain barrier and delivering drugs to the brain....
Autores principales: | Tian, Xin-hua, Wei, Feng, Wang, Tian-xiao, Wang, Peng, Lin, Xiao-ning, Wang, Jun, Wang, Dong, Ren, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3292416/ https://www.ncbi.nlm.nih.gov/pubmed/22403486 http://dx.doi.org/10.2147/IJN.S26541 |
Ejemplares similares
-
Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm
por: Tian, Xin-Hua, et al.
Publicado: (2013) -
Tat peptide-decorated gelatin-siloxane nanoparticles for delivery of CGRP transgene in treatment of cerebral vasospasm [Corrigendum]
Publicado: (2013) -
In Vivo Bio-distribution and Efficient Tumor Targeting of Gelatin/Silica Nanoparticles for Gene Delivery
por: Zhao, Xueqin, et al.
Publicado: (2016) -
Gelatin nanoparticle-mediated intranasal delivery of substance P protects against 6-hydroxydopamine-induced apoptosis: an in vitro and in vivo study
por: Lu, Cui-Tao, et al.
Publicado: (2015) -
The influence of siloxane side-chains on the photovoltaic performance of a conjugated polymer
por: Heintges, Gaël H. L., et al.
Publicado: (2019)